MedPath

Evaluation of disintegration time and palatability of mitiglinide-voglibose combined orally disintegrating tablet.

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000026208
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1.clearly taste disorder 2.allegy for drugs 3.pregnant and/or lactating women 4.other who was decided as inadequate by doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
palatability
Secondary Outcome Measures
NameTimeMethod
disintegrating time
© Copyright 2025. All Rights Reserved by MedPath